Funder
Regeneron Pharmaceuticals Inc
Subject
Pharmaceutical Science,General Medicine,Biotechnology
Reference15 articles.
1. Science and art of protein formulation development;Wang;Int. J. Pharm.,2019
2. M. Vázquez-Rey, D. A. Lang, Aggregates in monoclonal antibody manufacturing processes, Biotechnol. Bioeng. 108 (2011) 7. https://doi.org/10.1002/bit.23155.
3. Synergistic effects of flow and interfaces on antibody aggregation;Grigolato;Biotechnol. Bioeng.,2020
4. S. Bedi, M. P. Hwang, Y. Zhao, Y. Mao, A. S. Bhalla, N. Li, M. Shameem, Container Materials for Biopharmaceuticals: A comparative small-scale case study of stainless steel and a proprietary nickel-based alloy. Bioprocess Int. (2022). https://bioprocessintl.com/manufacturing/single-use/container-materials-for-biopharmaceuticals-a-comparative-small-scale-case-study-of-stainless-steel-and-a-proprietary-nickel-based-alloy/.
5. Aggregation and particle formation of therapeutic proteins in contact with a novel fluoropolymer surface versus siliconized surfaces: effects of agitation in vials and in prefilled syringes;Teska;J. Pharm. Sci.,2016